[Skip to Content]
[Skip to Content Landing]

Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Educational Objective
To understand a case where digitate papulosquamous eruption occurred in a patient infected with COVID-19
1 Credit CME

In December 2019 in Wuhan, China, a novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Common symptoms include fever, fatigue, cough, and shortness of breath.1 Although most cases result in mild symptoms, it is estimated that around 5% of patients develop severe pneumonia and multiorgan failure.2 A recent Italian study3 reported a spectrum of cutaneous eruptions with nonspecific features in more than 20% of a small cohort of patients with COVID-19. We report a case of a digitate papulosquamous eruption occurring during a SARS-CoV-2 infection.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Bethsabée Garel, MD, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Division of Dermatology and Venereology, Pavillon Tarnier, 89 rue d’Assas, 75006 Paris, France (bethsabee.garel@aphp.fr).

Published Online: April 30, 2020. doi:10.1001/jamadermatol.2020.1704

Conflict of Interest Disclosures: None reported.

References
1.
He  F , Deng  Y , Li  W .  Coronavirus disease 2019: what we know?   J Med Virol. Published online March 14, 2020. doi:10.1002/jmv.25766PubMedGoogle Scholar
2.
Wu  Z , McGoogan  JM .  Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.   JAMA. Published online February 24, 2020. doi:10.1001/jama.2020.2648PubMedGoogle Scholar
3.
Recalcati  S .  Cutaneous manifestations in COVID-19: a first perspective.   J Eur Acad Dermatol Venereol. Published online March 26, 2020. doi:10.1111/jdv.16387PubMedGoogle Scholar
4.
Qin  C , Zhou  L , Hu  Z ,  et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China.   Clin Infect Dis. Published online March 12, 2020. doi:10.1093/cid/ciaa248PubMedGoogle Scholar
5.
Drago  F , Broccolo  F , Rebora  A .  Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology.   J Am Acad Dermatol. 2009;61(2):303-318. doi:10.1016/j.jaad.2008.07.045PubMedGoogle ScholarCrossref
6.
Hall  LD , Eminger  LA , Hesterman  KS , Heymann  WR .  Epstein-Barr virus: dermatologic associations and implications, part I: mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders.   J Am Acad Dermatol. 2015;72(1):1-19. doi:10.1016/j.jaad.2014.07.034PubMedGoogle ScholarCrossref
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 CME points in the American Board of Surgery’s (ABS) Continuing Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close